325 related articles for article (PubMed ID: 27213956)
1. Biomimetic proteolipid vesicles for targeting inflamed tissues.
Molinaro R; Corbo C; Martinez JO; Taraballi F; Evangelopoulos M; Minardi S; Yazdi IK; Zhao P; De Rosa E; Sherman MB; De Vita A; Toledano Furman NE; Wang X; Parodi A; Tasciotti E
Nat Mater; 2016 Sep; 15(9):1037-46. PubMed ID: 27213956
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.
Martinez JO; Molinaro R; Hartman KA; Boada C; Sukhovershin R; De Rosa E; Kirui D; Zhang S; Evangelopoulos M; Carter AM; Bibb JA; Cooke JP; Tasciotti E
Theranostics; 2018; 8(4):1131-1145. PubMed ID: 29464004
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.
Molinaro R; Martinez JO; Zinger A; De Vita A; Storci G; Arrighetti N; De Rosa E; Hartman KA; Basu N; Taghipour N; Corbo C; Tasciotti E
Biomater Sci; 2020 Jan; 8(1):333-341. PubMed ID: 31714542
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles.
Zinger A; Sushnitha M; Naoi T; Baudo G; De Rosa E; Chang J; Tasciotti E; Taraballi F
ACS Nano; 2021 Apr; 15(4):6326-6339. PubMed ID: 33724785
[TBL] [Abstract][Full Text] [Related]
5. Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach.
Molinaro R; Evangelopoulos M; Hoffman JR; Corbo C; Taraballi F; Martinez JO; Hartman KA; Cosco D; Costa G; Romeo I; Sherman M; Paolino D; Alcaro S; Tasciotti E
Adv Mater; 2018 Apr; 30(15):e1702749. PubMed ID: 29512198
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic nanocarrier for direct cytosolic drug delivery.
Zhang Z; Cao W; Jin H; Lovell JF; Yang M; Ding L; Chen J; Corbin I; Luo Q; Zheng G
Angew Chem Int Ed Engl; 2009; 48(48):9171-5. PubMed ID: 19876988
[No Abstract] [Full Text] [Related]
7. Biomimetic and bioinspired nanoparticles for targeted drug delivery.
Gagliardi M
Ther Deliv; 2017 Mar; 8(5):289-299. PubMed ID: 28361608
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.
Palomba R; Parodi A; Evangelopoulos M; Acciardo S; Corbo C; de Rosa E; Yazdi IK; Scaria S; Molinaro R; Furman NE; You J; Ferrari M; Salvatore F; Tasciotti E
Sci Rep; 2016 Oct; 6():34422. PubMed ID: 27703233
[TBL] [Abstract][Full Text] [Related]
9. Reconstituted lipoprotein: a versatile class of biologically-inspired nanostructures.
Bricarello DA; Smilowitz JT; Zivkovic AM; German JB; Parikh AN
ACS Nano; 2011 Jan; 5(1):42-57. PubMed ID: 21182259
[TBL] [Abstract][Full Text] [Related]
10. Novel platforms for vascular carriers with controlled geometry.
Pillai JD; Dunn SS; Napier ME; DeSimone JM
IUBMB Life; 2011 Aug; 63(8):596-606. PubMed ID: 21721103
[TBL] [Abstract][Full Text] [Related]
11. Proteolipid protein interactions in transfectants: implications for myelin assembly.
Sinoway MP; Kitagawa K; Timsit S; Hashim GA; Colman DR
J Neurosci Res; 1994 Apr; 37(5):551-62. PubMed ID: 7518004
[TBL] [Abstract][Full Text] [Related]
12. The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and fischer rat thyroid cell lines.
Martín-Belmonte F; Puertollano R; Millán J; Alonso MA
Mol Biol Cell; 2000 Jun; 11(6):2033-45. PubMed ID: 10848627
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle aerosols: boon or bane for breathing?
Banerjee R
Nanomedicine (Lond); 2012 Jun; 7(6):795-8. PubMed ID: 22734636
[No Abstract] [Full Text] [Related]
14. Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach.
Rampado R; Biccari A; D'Angelo E; Collino F; Cricrì G; Caliceti P; Giordano F; Taraballi F; Pucciarelli S; Agostini M
Front Bioeng Biotechnol; 2022; 10():883034. PubMed ID: 35757799
[TBL] [Abstract][Full Text] [Related]
15. Polymeric capsule-cushioned leukocyte cell membrane vesicles as a biomimetic delivery platform.
Gao C; Wu Z; Lin Z; Lin X; He Q
Nanoscale; 2016 Feb; 8(6):3548-54. PubMed ID: 26804725
[TBL] [Abstract][Full Text] [Related]
16. Coating nanoparticles with cell membranes for targeted drug delivery.
Gao W; Zhang L
J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
[TBL] [Abstract][Full Text] [Related]
17. Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis.
Ying K; Zhu Y; Wan J; Zhan C; Wang Y; Xie B; Xu P; Pan H; Wang H
Bioact Mater; 2023 Feb; 20():449-462. PubMed ID: 35765468
[TBL] [Abstract][Full Text] [Related]
18. Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis.
Moulari B; Béduneau A; Pellequer Y; Lamprecht A
J Control Release; 2014 Aug; 188():9-17. PubMed ID: 24910194
[TBL] [Abstract][Full Text] [Related]
19. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
20. Ion-translocating properties of calcifiable proteolipids.
Swain LD; Boyan BD
J Dent Res; 1988 Mar; 67(3):526-30. PubMed ID: 2459167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
